FDA.reportPublic FDA data

0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe [Yusimry]

RxCUI
2640395
RxNorm name
0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe [Yusimry]
Display name
0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe [Yusimry]
Full name
0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe [Yusimry]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761216Yusimryadalimumab-aqvh351(k) BiosimilarRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YUSIMRYADALIMUMAB-AQVHMeitheal Pharmaceuticals Inc.4cab600d-6950-409f-a6d8-d447da22cd952025-10-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2640395
YUSIMRYADALIMUMAB-AQVHCoherus BioSciences Inccd0e7af2-7704-49ce-bde9-f645294b67882025-05-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2640395

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4cab600d-6950-409f-a6d8-d447da22cd95YUSIMRY 40 MG in 0.8 ML Prefilled Syringe [PSN] · 0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe [Yusimry] [SBD] · 0.8 ML Yusimry 50 MG/ML Prefilled Syringe [SY] · Yusimry 40 MG per 0.8 ML Prefilled Syringe [SY]46These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee20251031
cd0e7af2-7704-49ce-bde9-f645294b6788YUSIMRY 40 MG in 0.8 ML Prefilled Syringe [PSN] · 0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe [Yusimry] [SBD] · 0.8 ML Yusimry 50 MG/ML Prefilled Syringe [SY] · Yusimry 40 MG per 0.8 ML Prefilled Syringe [SY]46These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee20250516